C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/38 (2006.01) A61K 39/25 (2006.01) C07K 14/04 (2006.01) C07K 19/00 (2006.01) C12N 15/62 (2006.01) C12N 15/85 (2006.01) A61K 38/00 (2006.01) A61K 39/00 (2006.01)
Patent
CA 2152256
The present invention discloses methods for the production of Varicella-Zoster virus immediate early protein 175 (IEP 175) and derivatives thereof by recombinant technology - DNA and amino acid sequences are provided for IEP 175, structural or functional homologues, as well as fusion proteins and vectors adapted for eukaryotic host cells. Said protein and derivatives thereof are used as vaccines against VZV.
Bollen Alex
Haumont Michele
Jacobs Paul
Massaer Marc
Borden Ladner Gervais Llp
Smithkline Beecham Biologicals S.a.
LandOfFree
Vaccines against varicella-zoster virus (vzv) does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Vaccines against varicella-zoster virus (vzv), we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vaccines against varicella-zoster virus (vzv) will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1602149